Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction

Don Hayes; Mark Galantowicz; Andrew R. Yates; Thomas J. Preston; Heidi M. Mansour; Patrick I. McConnell

doi:10.1007/s10047-013-0699-z

Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction

Don Hayes, Mark Galantowicz, Andrew R. Yates, Thomas J. Preston, Heidi M. Mansour, Patrick I. McConnell

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO₂/FIO₂ (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.

Original language	English (US)
Pages (from-to)	382-385
Number of pages	4
Journal	Journal of Artificial Organs
Volume	16
Issue number	3
DOIs	https://doi.org/10.1007/s10047-013-0699-z
State	Published - Sep 2013
Externally published	Yes

Keywords

Cystic fibrosis
Lung transplantation
Preventative
Primary graft dysfunction
Protective
Venovenous extracorporeal membrane oxygenation

ASJC Scopus subject areas

Medicine (miscellaneous)
Biomaterials
Biomedical Engineering
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s10047-013-0699-z

Cite this

@article{2c4038290fa64bb88028b7206daedf63,

title = "Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction",

abstract = "Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.",

keywords = "Cystic fibrosis, Lung transplantation, Preventative, Primary graft dysfunction, Protective, Venovenous extracorporeal membrane oxygenation",

author = "Don Hayes and Mark Galantowicz and Yates, {Andrew R.} and Preston, {Thomas J.} and Mansour, {Heidi M.} and McConnell, {Patrick I.}",

year = "2013",

month = sep,

doi = "10.1007/s10047-013-0699-z",

language = "English (US)",

volume = "16",

pages = "382--385",

journal = "Journal of Artificial Organs",

issn = "1434-7229",

publisher = "Springer Japan",

number = "3",

}

TY - JOUR

T1 - Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction

AU - Hayes, Don

AU - Galantowicz, Mark

AU - Yates, Andrew R.

AU - Preston, Thomas J.

AU - Mansour, Heidi M.

AU - McConnell, Patrick I.

PY - 2013/9

Y1 - 2013/9

N2 - Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.

AB - Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.

KW - Cystic fibrosis

KW - Lung transplantation

KW - Preventative

KW - Primary graft dysfunction

KW - Protective

KW - Venovenous extracorporeal membrane oxygenation

UR - http://www.scopus.com/inward/record.url?scp=84885422894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885422894&partnerID=8YFLogxK

U2 - 10.1007/s10047-013-0699-z

DO - 10.1007/s10047-013-0699-z

M3 - Article

C2 - 23508264

AN - SCOPUS:84885422894

SN - 1434-7229

VL - 16

SP - 382

EP - 385

JO - Journal of Artificial Organs

JF - Journal of Artificial Organs

IS - 3

ER -

Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this